Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities

BACKGROUND: Co-occurring atopic conditions are common in children with peanut allergy. As such, it is important to examine the safety and efficacy of epicutaneous immunotherapy with Viaskin Peanut 250 μg patch (VP250) in peanut-allergic children with these conditions. OBJECTIVE: We sought to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Carla M., Lange, Lars, Beyer, Kirsten, Fleischer, David M., Ford, Lara, Sussman, Gordon, Oriel, Roxanne C., Pongracic, Jacqueline A., Shreffler, Wayne, Bee, Katharine J., Campbell, Dianne E., Green, Todd D., Lambert, Romain, Peillon, Aurélie, Bégin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509968/
https://www.ncbi.nlm.nih.gov/pubmed/37780103
http://dx.doi.org/10.1016/j.jacig.2022.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509968/
https://www.ncbi.nlm.nih.gov/pubmed/37780103
http://dx.doi.org/10.1016/j.jacig.2022.07.009

Ejemplares similares